CytoDyn Inc. reported earnings results for the first quarter ended August 31, 2022. For the first quarter, the company reported net loss was USD 20.99 million compared to USD 45.34 million a year ago. Basic loss per share from continuing operations was USD 0.03 compared to USD 0.07 a year ago.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1462 USD | -1.57% | -41.14% | -26.56% |
05-30 | Transcript : CytoDyn Inc. - Special Call | |
05-03 | CytoDyn Inc. announced that it has received $8.942 million in funding | CI |
1st Jan change | Capi. | |
---|---|---|
-26.56% | 146M | |
+18.00% | 123B | |
+14.80% | 107B | |
-4.36% | 24.01B | |
+2.18% | 22.59B | |
-10.09% | 18.16B | |
-41.04% | 16.84B | |
-11.87% | 16.23B | |
+2.37% | 13.43B | |
+25.48% | 11.32B |
- Stock Market
- Equities
- CYDY Stock
- News CytoDyn Inc.
- CytoDyn Inc. Reports Earnings Results for the First Quarter Ended August 31, 2022